Septra Injection 80 mg (Sulfamethoxazole SOLUTION) 80 MG

Sulfamethoxazole works by inhibiting the bacterial enzymes dihydropteroate synthase and dihydrofolate reductase, which are essential for the synthesis of folic acid in bacteria. By blocking these enzymes, it disrupts the bacterial folate synthesis pathway, leading to the inhibition of bacterial growth and replication.

The dosage of SEPTRA INJECTION is determined by a healthcare professional based on the type and severity of the infection, as well as the patient's overall health. It is important to follow the prescribed dosage and administration instructions provided by your doctor.

SEPTRA INJECTION should be used with caution during pregnancy, especially near term, as it may cause harm to the fetus. It should also be used with caution during breastfeeding, as it may pass into breast milk. Always consult your healthcare provider before using this medication if you are pregnant or breastfeeding.

To order SEPTRA INJECTION from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will reply with pricing, availability, shipping, and the import paperwork.

SEPTRA INJECTION is a combination antibiotic that includes sulfamethoxazole and trimethoprim, making it effective against a wide range of bacterial infections. Compared to other antibiotics, it is particularly useful in treating infections where resistance to single-agent antibiotics is a concern.

SEPTRA INJECTION should be stored at room temperature between 15° and 30°C and protected from light. It is important to keep the medication out of reach of children and to follow the storage instructions provided on the packaging.

SEPTRA INJECTION is administered intravenously under medical supervision. It is typically given as a slow IV infusion over 60–90 minutes. The dosage and administration schedule are determined by a healthcare professional based on the type and severity of the infection.

The most serious risks associated with SEPTRA INJECTION include severe skin reactions, blood dyscrasias, allergic reactions, kidney problems, and liver toxicity. It is important to monitor for these side effects and to seek medical attention if they occur.

SEPTRA INJECTION should not be used by individuals who are allergic to sulfa drugs or trimethoprim. It should also be used with caution in individuals with marked liver damage, severe renal insufficiency, megaloblastic anemia due to folate deficiency, and in pregnant women, especially near term, and infants under 2 months old.